The clinical problems of bacterial resistance to the new quinolones. 1990

J F Acar, and S Francoual
Hôpital Saint-Joseph, Laboratoire de Microbiologie Médicale, France.

Clinical problems of bacterial resistance to the new fluoroquinolones are emerging as their use increases. Emergence of resistant strains has been observed in various types of infections, especially of the respiratory tract. Only limited studies, however, deal with strains isolated from clinical specimens. The identity between the original strain and the resistant variant is rarely proved. Resistance to quinolones can be due to a modification in DNA gyrase or to an alteration in outer membrane permeability (pleiotropic resistance). Methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa have been recognized as species at risk of developing such resistance. Strategies to minimize the emergence of resistance are discussed.

UI MeSH Term Description Entries
D007592 Joint Diseases Diseases involving the JOINTS. Arthropathies,Arthropathy,Joint Disease
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D001847 Bone Diseases Diseases of BONES. Bone Disease,Disease, Bone,Diseases, Bone
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

J F Acar, and S Francoual
January 1989, Reviews of infectious diseases,
J F Acar, and S Francoual
January 1993, Drugs,
J F Acar, and S Francoual
October 1996, Nihon saikingaku zasshi. Japanese journal of bacteriology,
J F Acar, and S Francoual
March 2002, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
J F Acar, and S Francoual
January 1992, Archives de l'Institut Pasteur d'Algerie. Institut Pasteur d'Algerie,
J F Acar, and S Francoual
January 2017, Methods in molecular biology (Clifton, N.J.),
J F Acar, and S Francoual
April 1989, The Journal of antimicrobial chemotherapy,
J F Acar, and S Francoual
December 1987, Pharmaceutisch weekblad. Scientific edition,
J F Acar, and S Francoual
August 1948, Bulletin. New England Medical Center Hospital,
J F Acar, and S Francoual
March 2024, Life (Basel, Switzerland),
Copied contents to your clipboard!